Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001547522-16-000257)

Filing Details

Accession Number:: 0001547522-16-000257
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-12 12:32:01
Reporting Period:: 2016-07-08

Filing Date:: 2016-07-12
Accepted Time:: 2016-07-12 12:32:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
811641	Immucell Corp	ICCC	In Vitro & In Vivo Diagnostic Substances (2835)	010382980

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1136546	H Joseph Crabb	C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103	Vp & Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	341	$6.53	106,705	No	4	S	Direct
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	400	$6.50	106,305	No	4	S	Direct
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	100	$6.51	106,205	No	4	S	Direct
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	500	$6.55	105,705	No	4	S	Direct
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	394	$6.59	105,311	No	4	S	Direct
Common Stock, Par Value $0.10 Per Share	Disposition	2016-07-08	200	$6.60	105,111	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The transactions reported herein have been effectuated pursuant to a plan implemented by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.